Life Sciences and Industrial Biochemistry

Medicine Authorisations and SPCs in the UK after the implementation of the Windsor Framework

Nov 11, 2024 | Tags: Patents , IP Insight , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

News Flash - Update to EPO’s practices concerning the filing of sequence listings for European divisional applications

Oct 5, 2023 | Tags: Patents , IP Insight , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Compliant sequence listings for European divisionals post July 2022

Mar 10, 2023 | Tags: Patents , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Covid vaccine patent waivers – the opinion of our vaccine IP specialist

May 6, 2021 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Medical inventions – a European perspective

Jan 19, 2021 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals

No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

Jul 16, 2020 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals